Illuminate Clinical Cost Savings to Aid Financial Rebound from COVID

share us

  • Apr 15, 2020

Health systems face a myriad of financial and operational challenges in the wake of the COVID-19 crisis. As hospitals consider reestablishing revenue-generating surgical procedures, executives must uncover new savings opportunities while increasing supply chain resiliency.

Lumere and GHX have combined forces to shed some light on five key strategies:

  • Medical device cost savings strategies that won’t impact care quality or patient outcomes
  • How to assess which elective surgeries will perform the strongest financially
  • Strategies to improve supply chain collaboration with physicians
  • Financial benefits of accurately capturing supply information during clinical documentation
  • Bottom-line impact of leveraging holistic and interoperable data sourcesData/analysis

Hosts and Subject Matter Experts:
John Cherf, MD, MPH,MBA, Chief Medical Officer, Lumere
Dan Hermes, MBA, Solution Advisor, Lumere

Set up a Discovery Call to Learn More